Get started
Author

Xingxian Luo

Therapeutic Drug Monitoring and Individualized Medicine of Dasatinib: Focus on Clinical Pharmacokinetics and Pharmacodynamics
2021 · Shiyu He, Jialu Bian, et al. · Frontiers in Pharmacology · 38
PDF
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis
2021 · Ying Zhang, Kelu Hou, et al. · Mycoses · 37
Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021
2022 · Xingxian Luo, Xin Du, et al. · Clinical Pharmacology & Therapeutics · 36
The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysis
2022 · Xingxian Luo, Xin Du, et al. · The Lancet Regional Health - Western Pacific · 30
Evidence of pre-approval clinical trial supporting the granted conditional approval for novel cancer drugs in China between 2015 and 2022
2023 · Xingxian Luo, Xin Du, et al. · EClinicalMedicine · 24
PDF
Assessment of the breakthrough-therapy-designated drugs granted in China: A pooled analysis 2020–2022
2022 · Xingxian Luo, Feng Qian, et al. · Drug Discovery Today · 23
Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients
2020 · Xingxian Luo, Taifeng Li, et al. · Journal of Chemotherapy · 23
The impact of azole antifungal drugs on imatinib metabolism in human liver microsomes
2018 · Xingxian Luo, Taifeng Li, et al. · Xenobiotica · 19
Analysis of Patent and Regulatory Exclusivity for Novel Agents in China and the United States: A Cohort Study of Drugs Approved Between 2018 and 2021
2022 · Xingxian Luo, Lina Yang, et al. · Clinical Pharmacology & Therapeutics · 18
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation
2019 · Tai-feng Li, Lei Hu, et al. · Acta Pharmacologica Sinica · 18
PDF
Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in China
2023 · Xingxian Luo, Xin Du, et al. · JAMA Network Open · 16
PDF
Effectiveness and Economic Evaluation of Polyene Phosphatidyl Choline in Patients With Liver Diseases Based on Real-World Research
2022 · Jian-Gao Fan, Ying Li, et al. · Frontiers in Pharmacology · 16
Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China
2024 · Xin Du, Xingxian Luo, et al. · Frontiers in Public Health · 14
PDF
Intersection of immune signaling and cell death: The bidirectional regulatory mechanism of STING pathway and Ferroptosis
2025 · Yuxuan Yao, Xu He, et al. · Autoimmunity Reviews · 11
The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
2021 · Han Yao, Xingxian Luo, et al. · Frontiers in Pharmacology · 11
PDF
Individualized treatment with voriconazole in the Chinese population: Inflammation level as a novel marker for dose optimization
2023 · Xu Hao, Yuanyuan Li, et al. · British Journal of Clinical Pharmacology · 10
PDF
Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China
2024 · Xin Du, Xingxian Luo, et al. · Journal of Hematology & Oncology · 9
PDF
Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials
2025 · Xin Du, Zhong Zhao, et al. · The Lancet Oncology · 7
Evaluation of clinical trial designs for novel anticancer drugs in China: A cohort study of drugs approved between 2015 and 2021
2023 · Xingxian Luo, Qixiang Guo, et al. · Drug Discovery Today · 7
Clinical Benefit, Price, and Regulatory Approval of Cancer Drugs Granted Breakthrough Therapy Designation in China, 2020-2024
2024 · Xingxian Luo, Xin Du, et al. · JAMA Network Open · 6
PDF
Current regulatory status in China of drugs withdrawn from the US FDA accelerated pathway: implications for regulation globally
2024 · Xingxian Luo, Lin Huang, et al. · The Lancet Oncology · 6
Clinical trial evidence supporting FDA approval of novel orphan drugs between 2017 and 2023
2024 · Qi Chen, Yang Xu, et al. · Drug Discovery Today · 5
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS
2020 · Xingxian Luo, Xuecai Xue, et al. · Current Drug Metabolism · 5
An Integrated WebGIS-Based Mangement Platform of Geopark
2015 · Xingxian Luo · The Open Construction and Building Technology Journal · 5
PDF
A comparative analysis of vaccine lists, prices, and candidates, and the national immunization program between China and the United States
2024 · Xingxian Luo, Jingwen Liu, et al. · Acta Materia Medica · 4
PDF
Works count: 40
Citation count: 405
H-index: 13
I10-index: 16
Year
Topic
Type